Brown Advisory Inc P Lx Pharma Inc. Transaction History

Brown Advisory Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$3.01 - $6.7 $103,953 - $231,391	-34,536 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.83 - $4.21 $97,736 - $145,396	34,536 New	34,536 $112,000
Q2 2019 Aug 12, 2019	SELL	$4.93 - $7.2 $367,778 - $537,120	-74,600 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$1.22 - $4.38 $488 - $1,752	-400 Reduced 0.53%	74,600 $114,000
Q1 2018 Jun 28, 2018	BUY	$3.2 - $7.43 $240,000 - $557,250	75,000 New	75,000 $251,000
Q1 2018 May 14, 2018	SELL	$3.2 - $7.43 $352,000 - $817,300	-110,000 Closed	0 $0
Q4 2017 Feb 12, 2018	BUY	$6.3 - $9.1 $693,000 - $1 Million	110,000	110,000 $759,000

62.7K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.